Jacob Fog Bentzon

9.8k total citations · 3 hit papers
83 papers, 5.5k citations indexed

About

Jacob Fog Bentzon is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Jacob Fog Bentzon has authored 83 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 25 papers in Surgery and 25 papers in Molecular Biology. Recurrent topics in Jacob Fog Bentzon's work include Atherosclerosis and Cardiovascular Diseases (34 papers), Coronary Interventions and Diagnostics (11 papers) and Angiogenesis and VEGF in Cancer (11 papers). Jacob Fog Bentzon is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (34 papers), Coronary Interventions and Diagnostics (11 papers) and Angiogenesis and VEGF in Cancer (11 papers). Jacob Fog Bentzon collaborates with scholars based in Denmark, Spain and United Kingdom. Jacob Fog Bentzon's co-authors include Erling Falk, Renu Virmani, Fumiyuki Otsuka, Masataka Nakano, Aloke V. Finn, Mette K. Hagensen, Moustapha Kassem, Troels Thim, Claus S. Søndergaard and Ji Zhou and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Jacob Fog Bentzon

82 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Plaque Formation and Rupture

2014 1.6k citations Jacob Fog Bentzon, Erling Falk et al. Circulation Research profile →
Update on acute coronary syndromes: the pathologists' view

2012 727 citations Erling Falk, Jacob Fog Bentzon et al. profile →
Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry

2023 75 citations Martin Bødtker Mortensen, Omar Dzaye et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Fog Bentzon Denmark	31	1.7k	1.7k	1.5k	1.5k	891	83	5.5k
Makiko Ueda Japan	39	2.1k 1.2×	1.5k 0.9×	1.7k 1.2×	1.9k 1.3×	1.1k 1.2×	164	6.5k
Takahiko Naruko Japan	32	1.6k 0.9×	982 0.6×	1.4k 0.9×	1.7k 1.2×	667 0.7×	115	4.8k
Alessandro Mauriello Italy	38	930 0.5×	1.7k 1.0×	1.0k 0.7×	1.2k 0.9×	1.3k 1.5×	188	5.5k
Daniel T. Eitzman United States	38	789 0.5×	1.0k 0.6×	1.3k 0.8×	1.5k 1.1×	605 0.7×	100	5.2k
Yutaka Nakashima Japan	38	1.6k 0.9×	2.0k 1.2×	1.4k 0.9×	955 0.7×	1.2k 1.4×	124	6.7k
Jan Hinrich Bräsen Germany	35	1.1k 0.6×	2.0k 1.2×	1.2k 0.8×	600 0.4×	749 0.8×	134	5.4k
Caroline Cheng Netherlands	35	1.1k 0.6×	1.3k 0.8×	882 0.6×	1.1k 0.7×	710 0.8×	92	4.1k
Rafael Kramann Germany	47	1.3k 0.7×	2.7k 1.6×	681 0.4×	1.1k 0.7×	1.1k 1.2×	152	7.3k
Yutaka Furukawa Japan	40	2.3k 1.3×	1.1k 0.7×	643 0.4×	3.2k 2.2×	875 1.0×	269	6.1k
Daiju Fukuda Japan	35	1.6k 0.9×	867 0.5×	580 0.4×	1.8k 1.2×	585 0.7×	92	4.0k

Countries citing papers authored by Jacob Fog Bentzon

Since Specialization

Citations

This map shows the geographic impact of Jacob Fog Bentzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Fog Bentzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Fog Bentzon more than expected).

Fields of papers citing papers by Jacob Fog Bentzon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Fog Bentzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Fog Bentzon. The network helps show where Jacob Fog Bentzon may publish in the future.

Co-authorship network of co-authors of Jacob Fog Bentzon

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Fog Bentzon. A scholar is included among the top collaborators of Jacob Fog Bentzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Fog Bentzon. Jacob Fog Bentzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torroja, Carlos, Daniel Morales‐Cano, Rubén Mota, et al.. (2025). Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Science Translational Medicine. 17(811). eado6467–eado6467. 2 indexed citations

Hamczyk, Magda R., Rosa M. Nevado, Pilar Gonzalo, et al.. (2024). Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome. Circulation. 150(20). 1612–1630. 8 indexed citations

Fernández‐Barahona, Irene, et al.. (2024). Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis. Nanoscale. 16(13). 6477–6487. 1 indexed citations

Carramolino, Laura, Julián Albarrán-Juárez, Esther Hernández‐SanMiguel, et al.. (2024). Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes. Nature Cardiovascular Research. 3(2). 203–220. 10 indexed citations

Möller, Peter, Palle Duun Rohde, Laust Dupont Rasmussen, et al.. (2024). Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease. Genome Medicine. 16(1). 40–40. 3 indexed citations

Mortensen, Martin Bødtker, Omar Dzaye, Hans Erik Bøtker, et al.. (2023). Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry. Circulation. 147(14). 1053–1063. 75 indexed citations breakdown →

Möller, Peter, Palle Duun Rohde, Laust Dupont Rasmussen, et al.. (2023). Combining Polygenic and Proteomic Risk Scores With Clinical Risk Factors to Improve Performance for Diagnosing Absence of Coronary Artery Disease in Patients With de novo Chest Pain. Circulation Genomic and Precision Medicine. 16(5). 442–451. 3 indexed citations

López‐Melgar, Beatriz, Javier Sánchez‐Gonzalez, Robert Entrekin, et al.. (2022). New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume. JACC. Cardiovascular imaging. 15(6). 1124–1135. 11 indexed citations

Albarrán-Juárez, Julián, Daniel Morales‐Cano, Donal MacGrogan, et al.. (2021). Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development. Arteriosclerosis Thrombosis and Vascular Biology. 41(9). e427–e439. 23 indexed citations

10.

Mateo, Jesús, et al.. (2019). Abstract 191: 18F-Sodium Fluoride PET-CT Measures Plaque Burden in Gene Modified Minipigs with Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 1 indexed citations

11.

Wachenfeldt, Karin von, Anna-Karin L. Robertson, Jacob Fog Bentzon, et al.. (2018). Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. Journal of Diabetes Research. 2018. 1–12. 13 indexed citations

12.

Füchtbauer, Ernst‐Martin, et al.. (2017). Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs. JCI Insight. 2(19). 103 indexed citations

13.

Callesen, Henrik, et al.. (2017). 23 Production of Genetically Modified Founder Pigs as Models for Human Diseases. Reproduction Fertility and Development. 30(1). 151–151. 1 indexed citations

14.

Wachenfeldt, Karin von, Jacob Fog Bentzon, Lars B. Nielsen, et al.. (2016). Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions. International Journal of Cardiology. 215. 506–515. 17 indexed citations

15.

Bjørklund, Martin M., Anne Kruse Hollensen, Mette K. Hagensen, et al.. (2014). Induction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering. Circulation Research. 114(11). 1684–1689. 202 indexed citations

16.

Al‐Mashhadi, Rozh H., Esben Søvsø Szocska Hansen, Steffen Ringgaard, et al.. (2014). Abstract 17809: In Vivo High Resolution Isotropic 3D MRI of Coronary Atherosclerosis in Hypertensive Hypercholesterolemic Minipigs. Circulation. 130(suppl_2). 1 indexed citations

17.

Gustafsen, Camilla, Mads Kjølby, Mette Nyegaard, et al.. (2014). The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion. Cell Metabolism. 19(2). 310–318. 130 indexed citations

18.

Bentzon, Jacob Fog, et al.. (2006). Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 26(12). 2696–2702. 181 indexed citations

19.

Bro, Susanne, Jacob Fog Bentzon, Erling Falk, et al.. (2003). Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice. Journal of the American Society of Nephrology. 14(10). 2466–2474. 134 indexed citations

20.

Grønholdt, Marie-Louise M., et al.. (2002). Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels*1. Journal of Vascular Surgery. 35(1). 137–145. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact